retatrutide and blood sugar New Kind of Diabetes Drug Helped People Lower Lose Almost 40 Pounds Retatrutide vs Tirzepatide (2026): Differences

Improved Glycemic Control : Individuals with type 2 diabetes benefit immensely from the glucose-regulating effects of GLP-1 agonists, which enhance insulin secretion and inhibit glucagon production, promoting better glycemic control

Priority review status, likely given obesity drug precedents, shortens FDA review to approximately six months rather than the standard ten to twelve months

During this time, many also notice improvements in blood sugar control, which is especially beneficial for individuals with type 2 diabetes

GLP-1, short for glucagon-like peptide-1, is one of the best-known incretin pathways involved in insulin-related signaling and appetite regulation